BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 2

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Nirsevimab, Season 2

MMWR recomm. rep; 72 (34), 2023
A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms for the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV))-associated lower respiratory tract infec...
Anticorpos Monoclonais/uso terapêutico, Vírus Sinciciais Respiratórios/imunologia
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): GSK RSVPreF3 Vaccine (AREXVY)

MMWR recomm. rep; 79 (29), 2023
A Grading of Recommendations, Assessment, Development and Evaluation (GRADE) review of the evidence for benefits and harms for GSK Respiratory Syncytial Virus (RSV) PreF3 vaccine was presented to the Advisory Committee on Immunization Practices (ACIP) on June 21, 2023. GRADE evidence type indicates the c...
Vacinas contra Influenza/uso terapêutico, Vírus Sinciciais Respiratórios/imunologia, Desenvolvimento de Vacinas
Texto completo